Sequana Medical NV (EBR:SEQUA)

Sequana Medical NV Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	41	136	113	142	140	186
Market Cap Growth	-51.91%	20.36%	-20.71%	1.45%	-24.57%	135.83%
Enterprise Value	75	154	113	127	126	175
Last Close Price	0.57	3.06	4.00	6.00	7.56	11.80
PS Ratio	-	1288.86	158.63	154.42	379.06	193.28
PB Ratio	-1.04	-3.06	-5.80	-66.17	-178.47	1651.17
P/TBV Ratio	-	-	-	-	-	1651.17
EV/Sales Ratio	-	1461.18	159.36	138.00	340.36	181.37
Debt / Equity Ratio	-1.06	-0.90	-0.90	-8.17	-10.27	69.70
Net Debt / Equity Ratio	-0.87	-0.82	-0.77	0.60	1.93	-27.99
Net Debt / EBITDA Ratio	-1.98	-1.97	-0.51	0.05	0.06	0.18
Net Debt / FCF Ratio	-1.93	-1.78	-0.50	0.05	0.06	0.18
Asset Turnover	-	0.01	0.04	0.05	0.03	0.08
Inventory Turnover	0	0.01	0.07	0.09	0.04	0.13
Quick Ratio	0.15	0.08	0.15	1.27	1.39	1.90
Current Ratio	0.20	0.12	0.32	1.52	1.80	2.25
Return on Equity (ROE)	-	-	-	-	-	-3678.90%
Return on Assets (ROA)	-88.40%	-116.66%	-102.04%	-87.85%	-102.95%	-94.27%
Return on Capital Employed (ROCE)	47.70%	43.20%	314.90%	-263.20%	-316.50%	-215.50%
Earnings Yield	-127.38%	-32.84%	-28.82%	-21.59%	-16.81%	-10.26%
FCF Yield	-43.46%	-14.97%	-26.36%	-19.76%	-17.05%	-9.21%
Buyback Yield / Dilution	-54.42%	-37.26%	-17.59%	-25.02%	-18.96%	-24.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.